Finance

Lists
Why is KROS down 2,72%?
Dive Deeper
KROS:NASDAQ
Keros Therapeutics Inc
US$11,08
-2,72%
(-0,31) 1D
US$11,08
0,00% (0,00)
After hours
Closed: 20 ພ.ຈ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for KROS...
Open
US$11,18
High
US$11,59
Low
US$10,95
Mkt. cap
217,44 ລ້ານ
Avg. vol.
210,29 ພັນ
Volume
208,70 ພັນ
52-wk high
US$22,55
52-wk low
US$8,98
EPS
US$-2,83
Beta
1,13
Shares outstanding
19,62 ລ້ານ
No. of employees
87
Open
US$11,18
High
US$11,59
Low
US$10,95
Mkt. cap
217,44 ລ້ານ
Avg. vol.
210,29 ພັນ
Volume
208,70 ພັນ
52-wk high
US$22,55
52-wk low
US$8,98
EPS
US$-2,83
Beta
1,13
Shares outstanding
19,62 ລ້ານ
No. of employees
87
News stories
From web sources and news partners
About Keros Therapeutics Inc
CEO-
Employees87
Founded2015
HeadquartersLexington, ມາຊາຊູເຊັດ, ສະຫະລັດ
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 4 analysts giving stock ratings to KROS in the past 3 months
Buy
Buy
2
Hold
2
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for KROS in the last 3 months.
Highest
Current US$11,08
US$20,00 (+80,51%)
Average
US$18,00 (+62,45%)
Lowest
US$16,00 (+44,40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason Zemansky
Bank of America Securities
Hold
Reiterated
US$18,00
+62,5%
11/16/2026
Yun Zhong
Wedbush
Hold
Maintained
US$16,00
+44,4%
11/09/2026
Andres Y. Maldonado
H.C. Wainwright
Buy
Reiterated
US$20,00
+80,5%
11/06/2026
Benjamin Burnett
Wells Fargo
Buy
Maintained
US$18,00
+62,5%
09/02/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
08/04/2026
Thomas Smith
Leerink Partners
Buy
Maintained
US$23,00
+107,6%
08/04/2026
Nicholas Lorusso
TD Cowen
Hold
Reiterated
-
-
08/04/2026
Srikripa Devarakonda
Truist Financial
Buy
Maintained
-
-
05/15/2026
Andreas Argyrides
Oppenheimer
Buy
Maintained
US$27,00
+143,7%
03/09/2026
Unknown Analyst
Leerink Partners
Buy
Reiterated
US$30,00
+170,8%
03/06/2026
Tiago Fauth
Raymond James
Buy
Maintained
US$20,00
+80,5%
03/05/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
ກ.ຍ. 2026
Revenue
385,00 ພັນ
367,00 ພັນ
-
40,01 ລ້ານ
Cost of goods sold
17,81 ລ້ານ
16,10 ລ້ານ
22,33 ລ້ານ
20,49 ລ້ານ
Cost of revenue
17,81 ລ້ານ
16,10 ລ້ານ
22,33 ລ້ານ
20,49 ລ້ານ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,74 ລ້ານ
10,15 ລ້ານ
8,61 ລ້ານ
6,70 ລ້ານ
Operating expense
11,74 ລ້ານ
10,15 ລ້ານ
8,61 ລ້ານ
6,70 ລ້ານ
Total operating expenses
29,56 ລ້ານ
26,24 ລ້ານ
30,94 ລ້ານ
27,19 ລ້ານ
Operating income
-29,17 ລ້ານ
-25,88 ລ້ານ
-30,94 ລ້ານ
12,82 ລ້ານ
Other non operating income
-539,00 ພັນ
-
-60,00 ພັນ
-
EBT including unusual items
-24,98 ລ້ານ
-23,71 ລ້ານ
-28,71 ລ້ານ
14,92 ລ້ານ
EBT excluding unusual items
-24,88 ລ້ານ
-23,71 ລ້ານ
-28,71 ລ້ານ
14,92 ລ້ານ
Income tax expense
-1,51 ລ້ານ
-
-
772,00 ພັນ
Effective tax rate
6,06%
-
-
5,17%
Other operating expenses
-
-
-
-
Net income
-23,46 ລ້ານ
-23,71 ລ້ານ
-28,71 ລ້ານ
14,15 ລ້ານ
Net profit margin
-6.093,77%
-6.459,95%
-
35,37%
Earnings per share
-0,86
-1,21
-1,45
0,70
Interest and investment income
4,02 ລ້ານ
2,34 ລ້ານ
2,29 ລ້ານ
2,28 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
4,02 ລ້ານ
2,34 ລ້ານ
2,29 ລ້ານ
2,28 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-28,77 ລ້ານ
-25,47 ລ້ານ
-30,54 ລ້ານ
13,20 ລ້ານ
Gain or loss from assets sale
1,00 ພັນ
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
ແອັບຂອງ Google